✦ LIBER ✦

Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease

✍ Scribed by Tadayasu Togawa; Ikuo Kawashima; Takashi Kodama; Takahiro Tsukimura; Toshihiro Suzuki; Tomoko Fukushige; Takuro Kanekura; Hitoshi Sakuraba

Book ID: 116300684
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 400 KB
Volume: 399
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2010.08.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma globotriaosylsphingosine (lysoGb3

Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)

✍ Liao, Hsuan-Chieh; Huang, Yu-Hsiu; Chen, Yann-Jang; Kao, Shu-Min; Lin, Hsiang-Yu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 684 KB

PSY62 HEALTH TECHNOLOGY ASSESSMENT FOR R

PSY62 HEALTH TECHNOLOGY ASSESSMENT FOR RARE DISEASES: A MARKOVIAN MODEL FOR FABRY DISEASE (FD) CONSIDERING ENZYME REPLACEMENT THERAPY(ERT)

✍ Vinhas, de; Souza, M; Schwartz, I 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Tissue-specific X chromosome inactivatio

Tissue-specific X chromosome inactivation studies as a decision-making criteria for enzyme replacement therapy in female heterozygotes for Fabry disease

✍ Germain, Dominique P.; Echevarria, Lucia 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Plasma chitotriosidase in male Fabry pat

Plasma chitotriosidase in male Fabry patients: A marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy

✍ A.C. Vedder; J. Cox-Brinkman; C.E.M. Hollak; G.E. Linthorst; J.E.M. Groener; M.T 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A randomised, double-blind, placebo-cont

A randomised, double-blind, placebo-controlled, crossover study to assess the efficacy and safety of three dosing schedules of agalsidase alfa enzyme replacement therapy for Fabry disease

✍ Hughes, D.A.; Deegan, P.B.; Milligan, A.; Wright, N.; Butler, L.H.; Jacobs, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 283 KB

The Mainz Severity Score Index: a new in

The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy

✍ C Whybra; C Kampmann; F Krummenauer; M Ries; E Mengel; E Miebach; F Baehner; K K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB